DOXEPIN vs DOXORUBICIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DOXEPIN vs DOXORUBICIN: Safety Overview
| Metric | DOXEPIN | DOXORUBICIN |
|---|---|---|
| Total FAERS Reports | 4,021 | 82,754 |
| Deaths Reported | 1,613 | 15,653 |
| Death Rate | 40.1% | 18.9% |
| Hospitalizations | 1,091 | 28,630 |
| Average Patient Age | 49.2 yrs | 50.5 yrs |
| % Female Patients | 63.8% | 53.9% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Approved Prior to Jan 1, 1982 |
| Manufacturer | Teva Pharmaceuticals USA, Inc. | Hikma Pharmaceuticals USA Inc. |
| Route | TOPICAL | INTRAVENOUS |
| Marketing Status | Discontinued | Discontinued |